Bayer Healthcare Llc patents expiration
1. Claritin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6132758 | BAYER HEALTHCARE LLC | Stabilized antihistamine syrup |
Jun, 2018
(5 years ago) | |
Drugs and Companies using LORATADINE ingredient
Market Authorisation Date: 27 November, 2002
Treatment: NA
Dosage: SYRUP;ORAL
How can I launch a generic of CLARITIN before it's drug patent expiration?
More Information on Dosage
CLARITIN family patents
2. Claritin-d 24 Hour patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5314697 | BAYER HEALTHCARE LLC | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
Oct, 2012
(11 years ago) | |
|
US5314697 (Pediatric) | BAYER HEALTHCARE LLC | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
Apr, 2013
(11 years ago) | |
Drugs and Companies using LORATADINE; PSEUDOEPHEDRINE SULFATE ingredient
Market Authorisation Date: 27 November, 2002
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of CLARITIN-D 24 HOUR before it's drug patent expiration?
More Information on Dosage
CLARITIN-D 24 HOUR family patents